California Congresswoman Barbara Lee (D) CA discusses the record number of interest of women possibly seeking campaigns for Congress this year.
Lee's advice to women is that if they're thinking about it, don't think too long, because there are issues that need to be solved in this country.
She also talks the difficulties women, and black women in particular, face when running campaigns. She focuses particularly on the difficulties in finding funding opportunities.
She also talks about how powerful women are as leaders, and their ability to tackle issues that not only pertain to women, but all Americans.
The Florida GOP suspended its chairman yesterday amid a police investigation into a rape accusation against him.
Lawmakers may finally be close to a deal for a new border security bill.
A car crashed into a parked Secret Service SUV that was guarding President Biden's motorcade in Delaware on Sunday.
A car plowed into a parked SUV that was guarding President Joe Biden’s motorcade Sunday night while the president was leaving a visit to his campaign headquarters.
Negotiators insist they are making progress, but a hoped-for framework did not emerge. The talks come as Donald Trump, the Republican presidential front-runner in 2024, delivered alarming anti-immigrant remarks about “blood” purity over the weekend, echoing Nazi slogans of World War II at a political rally.
The Supreme Court decided to leave in place a ban on semi-automatic weapons in the state of Illinois.
The Senate passed a bill giving retroactive pay increases to those service members who may have been affected by the hold on military promotions caused by Senator Tommy Tuberville.
Jurors are expected to resume deliberations this morning in a case that centers on how much Donald Trump's former lawyer Rudy Giuliani must pay in his damages defamation trial.
President Biden said Israel needs to be more careful when it comes to civilian deaths in its war with Hamas as the next phase of the war is weeks away.
The White House has unveiled a list of 48 drugs that drugmakers will have to pay rebates to the federal government on due to raising their prices higher than the cost of inflation during this year.
